Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia

• Main Authors: Bala Munipalli (Author), Madeleine E. Allman (Author), Mohit Chauhan (Author), Shehzad K. Niazi (Author), Fernando Rivera (Author), Andy Abril (Author), Benjamin Wang (Author), Mikolaj A. Wieczorek (Author), David O. Hodge (Author), Dacre Knight (Author), Adam Perlman (Author), Abd Moain Abu Dabrh (Author), Daniel Dudenkov (Author), Barbara K. Bruce (Author)
• Format: Book
• Published: SAGE Publishing, 2022-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: About 4 out of 10 fibromyalgia patients suffer from depression. The European Alliance of Associations for Rheumatology (EULAR) guidelines recommend using antidepressants to treat fibromyalgia. Objective: To determine predictors of improved outcomes following a multicomponent treatment pr...